Navigation Links
Trubion Pharmaceuticals Provides Announcement Dates for Second Quarter and First Six Months Earnings Conference Call
Date:7/31/2008

SEATTLE, July 31 /PRNewswire-FirstCall/ -- Trubion Pharmaceuticals Inc. (Nasdaq: TRBN) today announced that it plans to issue earnings results for second quarter and first six months ended June 30, 2008, after the close of market on Aug. 7, 2008. The company's earnings conference call will take place Aug. 7, 2008, at 2 p.m. PDT (5 p.m. EDT).

Both live events will be available for viewing on Trubion's website at http://investors.trubion.com/events.cfm.

Second Quarter and First Six Months Earnings Conference Call: 2 p.m. PDT / 5 p.m. EDT, Aug. 7, 2008

Trubion will host a conference call and webcast to discuss its second quarter and six months 2008 financial results. The call will be held Aug. 7 at 2 p.m. Pacific time (5 p.m. Eastern time). The live event will be available from Trubion's website at http://investors.trubion.com/events.cfm, or by calling 1 (719) 325-4916 or 1 (877) 397-0292. A replay of the discussion will be available from Trubion's website or by calling 1 (719) 457-0820 or 1 (888) 203-1112 and entering 6969493. Replay will be available at 8 p.m. EDT until midnight, Aug. 14, 2008. The webcast replay will be available in the events section of Trubion's website.

About Trubion

Trubion is a biopharmaceutical company that is creating a pipeline of novel protein therapeutic product candidates to treat autoimmune and inflammatory diseases and cancer. The company's mission is to develop a variety of first-in-class and best-in-class product candidates, customized for optimal safety, efficacy, and convenience that it believes may offer improved patient experiences. Tr
'/>"/>

SOURCE Trubion Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Trubion Announces Presentations at Upcoming Investor Conferences
2. Trubion Pharmaceuticals Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
6. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
7. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
8. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
9. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
10. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
11. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Surgeons at the Forbes Hospital Trauma ... are exploring an innovative use of Google Glass technology, ... (VIZR), to assist in the care of critically injured ... wearable technology with an optical head-mounted display that provides ... the Internet via natural language voice commands. , Forbes’ ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 Ticket Down ... at the Hollywood Bowl . This popular site has ... appreciation promo code JIMMY-BUFFETT-2015 for added savings. , Parrotheads ... favorite performer will be headlining at the Hollywood Bowl ... will be on Thursday, October 22nd and it will ...
(Date:3/2/2015)... 02, 2015 Doctors in Novara, Italy ... better predictor of outcomes for people with mesothelioma than ... of the new study on the Surviving Mesothelioma ... University of Eastern Piedmont followed the cases of 172 ... for excess lung fluid. , “Persistent lung expansion ...
(Date:3/2/2015)... 2015 Burns Engineering's Lab-to-Lab Calibration ... Secondary Standard Platinum Resistance Thermometers (SSPRTs) and industrial ... or less . . . guaranteed. ... (Lab Code 200706-0), ISO 9001 and 17025 Certified ... is -196°C to 500°C, both ITS-90 and Callendar-van ...
(Date:3/2/2015)... March 02, 2015 The minimally ... at a CAGR of 6.1% to reach $14,133.0 ... , Factors such as advantages of minimally ... costs owing to minimally invasive surgeries and increasing ... are driving the global minimally invasive surgical instruments ...
Breaking Medicine News(10 mins):Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 2Health News:Pennsylvania Hospital Explores Use of Google Glass for Trauma Care 3Health News:Cheap Jimmy Buffett Tickets Hollywood Bowl: Ticket Down Slashes Prices on Jimmy Buffett Tickets at the Hollywood Bowl in Los Angeles/Hollywood, CA 2Health News:New Research Links Talc Treatment Response with Mesothelioma Prognosis, According to Surviving Mesothelioma 2Health News:Burns Engineering Announces Quick-Turn Temperature Calibrations 2Health News:Minimally Invasive Surgical Instrument Market - Global Forecast to 2019 - New Report by MarketsandMarkets 2
... epilepsy drug would help alcoholics quit drinking. Texas Health ... the alcoholics who took Topiramate, an anti-seizure drug quit ... placebo treatment, those given Topiramate were six times more ... the drug acts against the chemicals that provide pleasure ...
... fatter not because they are eating more, but because ... diet, weight, and physical activity of teens they found ... 1%, while physical activity dropped 13%. Even though experts ... agree teens have not been overeating. The study indicated ...
... capable of sniffing out distinctive odor of lung cancer patients. ... be accurate. The electronic nose is a 12 cm cube ... asked to exhale into a sterilized bag which is connected ... cube and hence into the sensors. The sensors identify the ...
... main cause of deadly brain-wasting diseases might be just ... - Cannibalism. Abnormal proteins called the prions resultantly ... and bovine spongiform encephalopathy, or mad cow disease in ... to be clumped together. CJD is usually found in ...
... Alzheimer’s disease continues to fuel research, as the incidence ... drug has been developed to slow the course of ... which is one of the brain’s messenger and this ... memory are the fields, which are enabled by the ...
... regular mammograms could reduce their risk of dying from ... and medical community as a benefit to women. However ... the 70's and 80's concluded X-rays can cut deaths ... it was impossible to tell if routine mammograms saved ...
Cached Medicine News:Health News:Brain diseases an outcome of cannibalism, 2
(Date:3/2/2015)... , March 2, 2015  CytomX, a biotechnology ... cancer, today announced the creation of scientific and ... clinicians in the fields of cancer immunotherapy and ... advisory boards will provide guidance to CytomX on ... precision immunotherapies and Probody drug conjugates. The company ...
(Date:3/2/2015)... 2015   Mast Therapeutics, Inc. (NYSE ... preliminary findings from a randomized, placebo-controlled, nonclinical study ... stable heart failure produced by intracoronary microembolizations.  The ... the effects of repeat intravenous administration of vepoloxamer ... Consistent with results of a ...
(Date:3/2/2015)... , March 2, 2015  Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis on ... that Company management will participate in the upcoming 27 ... 8-11, 2015 at the Ritz Carlton Laguna Niguel in ... Simpson , PhD, MSN, CRNP, Delcath,s interim President and ...
Breaking Medicine Technology:CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 2Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 3Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 4Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 5Mast Announces Results From Nonclinical Study Investigating Repeat Treatment With Vepoloxamer In Advanced Heart Failure 6Delcath To Present At The 27th Annual Roth Conference 2Delcath To Present At The 27th Annual Roth Conference 3
... public health professionals today were honored with GlaxoSmithKline ... through a variety of programs, including school health ... care for at-risk families. All nominees were recognized ... Wilmington during the North Carolina Public Health Association,s ...
... Calif., Oct. 27 Accuray Incorporated (Nasdaq: ARAY ... announced that the Korea Cancer Care Hospital (KCCH) in Seoul, ... marking the first hospital in the country – and Asia ... The recently acquired CyberKnife System is located at the ...
Cached Medicine Technology:GlaxoSmithKline Applauds North Carolina's Child Advocates 2GlaxoSmithKline Applauds North Carolina's Child Advocates 3GlaxoSmithKline Applauds North Carolina's Child Advocates 4GlaxoSmithKline Applauds North Carolina's Child Advocates 5GlaxoSmithKline Applauds North Carolina's Child Advocates 6Eighth CyberKnife System in South Korea Installed and Treating Patients 2Eighth CyberKnife System in South Korea Installed and Treating Patients 3Eighth CyberKnife System in South Korea Installed and Treating Patients 4
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Inquire...
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Medicine Products: